Tech Company Financing Transactions
CDI Bioscience Funding Round
Battelle Ventures and Innovation Valley Partners participated in a $3 million Series A funding round for CDI Bioscience. This VC investment round was announced on 12/11/2007.
Transaction Overview
Company Name
Announced On
12/11/2007
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Battelle Ventures (Mort Collins)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3587 Anderson St. 103
Madison, WI 53704
USA
Madison, WI 53704
USA
Phone
Website
Email Address
Overview
CDI Bioscience has developed a patented technology that dramatically improves the product yield in biopharmaceutical manufacturing. Our RP Shift technology facilitates up to 10 fold increase in byproduct yields while scaling down the required bioreactor capacity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Primiano
Browse more venture capital transactions:
Prev: 12/11/2007: INSIDE Secure venture capital transaction
Next: 12/11/2007: TechForward venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs